Nanostructured microcarriers based on silicon for drug delivery
暂无分享,去创建一个
F. Craciunoiu | M. Miu | I. Kleps | M. Simion | M. Danila | A. Bragaru | T. Ignat | E. Tirifon | R. Anghel | A. Popovici | S. Cinca
[1] Monica Simion,et al. Nanostructured silicon particles for medical applications. , 2010, Journal of nanoscience and nanotechnology.
[2] Vesa-Pekka Lehto,et al. Fabrication and chemical surface modification of mesoporous silicon for biomedical applications , 2008 .
[3] J. Salonen,et al. Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles. , 2007, International journal of pharmaceutics.
[4] W. Freeman,et al. Porous silicon in drug delivery devices and materials. , 2008, Advanced drug delivery reviews.
[5] O. Kayser,et al. The impact of nanobiotechnology on the development of new drug delivery systems. , 2005, Current pharmaceutical biotechnology.
[6] Vesa-Pekka Lehto,et al. In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[7] Mihai Danila,et al. Nanoporous silicon matrix used as biomaterial , 2007 .
[8] Mauro Ferrari,et al. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. , 2009, Biomaterials.